3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Dermatologic
3
Thoracic
2
Head & Neck
2
Genitourinary
2
Gastrointestinal
2
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Gynecologic
1
Endocrine
1
CNS
1
Breast
1
Conditions
Sarcoma
16
Central Nervous System Neoplasms
10
Gliosarcoma
9
Glioblastoma
9
Osteosarcoma
8
Astrocytoma
6
Sarcoma, Ewing
5
Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma
3
Lung Neoplasms
3
Breast Neoplasms
3
Brain Neoplasms
3
Waldenstrom Macroglobulinemia
2
Stomach Neoplasms
2
Recurrence
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Oligodendroglioma
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Melanoma
2
Lymphoma, Extranodal NK-T-Cell
2
Liver Neoplasms
2
Leukemia, Myelomonocytic, Juvenile
2
Leukemia
2
Glioma
2
Esophageal Neoplasms
2
Dendritic Cell Sarcoma, Interdigitating
2
Colorectal Neoplasms
2
Interventions
Specimen Handling
2
Semaxinib
2
tin etiopurpurin
1
pembrolizumab
1
montanide ISA 51
1
cc-486
1
atezolizumab
1
Tumor Necrosis Factor-alpha
1
Tissue Banks
1
SUB1 protein, human
1
Ritonavir
1
Radiosurgery
1
Quality of Life
1
Patient Reported Outcome Measures
1
Observation
1
Nelfinavir
1
Molecular Diagnostic Techniques
1
Mohs Surgery
1
Melphalan
1
Interleukin-2
1
Interleukin-12
1
Injections
1
Immunotherapy
1
Etoposide
1
Drug Therapy
1
Cyclophosphamide
1
Blood Specimen Collection
1
Biopsy
1
Biological Therapy
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Skin Neoplasms
×
Drug Therapy
×
Sarcoma
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled